newsfilter

$CYBX News

Last published 5y ago

  • 5y agoBEATGMEDGTHXHOLX+10IMPULSE DYNAMICS APPOINTS FIVE NEW BOARD MEMBERSGlobeNewswireMARLTON, N.J., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Impulse Dynamics N.V., a company dedicated to improving the lives of people with heart failure (HF), today announced the election of five new members to its Board of Directors at the most recent meeting
  • 5y agoHSDTLIVNCYBXHelius Medical Technologies, Inc. Appoints Frederick Fantazzia as Vice President of Sales & Marketing, North AmericaGlobeNewswireNEWTOWN, Pa., June 02, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced the appointment of Frederick Fantazzia to the p
  • 11y agoCYBXSorin and Cyberonics Announce Appointment of LivaNova’s Chief Financial OfficerBusiness WireMILAN & HOUSTON--(BUSINESS WIRE)--Sorin S.p.A., (MIL:SRN) (MTA; Reuters Code: SORN.MI, “Sorin”), a global medical device company and a leader in the treatment of cardiovascular diseases, and Cyberonics, Inc. (NASDAQ: CYBX, “Cyberonics”), a medical device company with core expertise in neuromodulation, today announced the appointment of Vivid Sehgal as Chief Financial Officer of LivaNova PLC (“Liva ...
  • 11y agoCYBXSorin and Cyberonics Announce Designees to Board of Directors of Combined CompanyBusiness WireMILAN, Italy & HOUSTON, Texas--(BUSINESS WIRE)--Sorin S.p.A. (MIL:SRN), (MTA; Reuters Code: SORN.MI “Sorin”), a global medical device company and a leader in the treatment of cardiovascular diseases, and Cyberonics, Inc. (NASDAQ: CYBX, “Cyberonics”), a medical device company with core expertise in neuromodulation, today announced their respective designees to the Board of Directors of the combined ...
  • 11y agoCYBXSorin-Cyberonics Merger Receives U.S. Antitrust ApprovalBusiness WireMILAN & HOUSTON--(BUSINESS WIRE)--Sorin S.p.A. (MIL:SRN) (MTA; Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, and Cyberonics, Inc. (NASDAQ:CYBX), a medical device company with core expertise in neuromodulation, today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amende ...